Precigen

Develops precision gene and cell therapies for intractable diseases.

Founded 1998 · 145 employees · United States · Public

Listed:

NASDAQ: PGEN

Subsidiaries:

PGEN Therapeutics, Precigen ActoBio, Precigen Exemplar